Case Studies > Non-small cell lung cancer
COUCH Health were commissioned by a leading biotech company to co‑create patient‑facing study materials for an upcoming phase 2/3 clinical study with people living with lung cancer within Black and African American communities in the US.
The client wanted to understand the perspectives of people with lung cancer who are currently underserved in clinical research to ensure their patient-facing study materials were appropriate and inclusive.
In the US, Black and African American people have been historically underrepresented in clinical research, despite being disproportionately affected by diseases such as cancer.
Lung cancer is the leading cause of cancer mortality in the US, accounting for 1 in 5 of all cancer deaths.
Black men are 12% more likely to develop lung cancer than White men.
While lung cancer rates are lower in Black and White women than in men, the gender gap is narrowing due to increasing incidence rates among women.
COUCH Health proposed 2 strategies for gathering insights and feedback from individuals with lung cancer from black and African American communities in the US:
6 individuals participated – 5 people living with lung cancer and 1 care partner
To co-create the patient-facing materials, we gained insights on appropriate:
Based on the insights obtained, we co-created several patient-facing materials tailored to meet the needs of black and African American communities:
UK address
COUCH Health
5 Richmond Street
Manchester, M1 3HF
+44 (0) 161 300 0874
US address
1111B S Governors Ave
STE 21906,
Dover, DE 19904
+1 321 985 1511
hello@couchhealth.agency
Receive exclusive insights from our experts on important topics and news within the inclusive clinical research space.